This might be the updated cytoprotection concept [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40], as innate epithelial and endothelial cell protection was long ago postulated in the stomach [41,42,43,44,45,46,47,48]
GSH transport into mitochondria appears to be mediated in part by the dicarboxylate carrier (DIC, Slc25a10) and the oxoglutarate carrier (OGC, Slc25a11) (Lash, 2006), whereas transport into the nucleus probably occurs by passive diffusion through the nuclear pores
The scientific community consensus maintains that until well-designed clinical trials are conducted, BPC-157 should be considered investigational
Rejuvenation (Epitalon) 0.5mg sublingual tablet Peptide therapy utilizes Epitalon for its anti-aging and anti-carcinogenic properties